HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk



The Practical Cardiology™ Arrhythmia clinical resource center provides information and insights for those interested in the latest from the field of heart rhythm disorders. From atrial fibrillation to ventricular tachycardia and everything in between, this page is where readers can find articles, videos, podcasts, and conference coverage related to arrhythmias and electrophysiology.

Despite Advances, Room for Improvement in Anticoagulation Exists for Older Adults

November 21, 2022

An analysis of data from Medicare beneficiaries receiving treatment over a decade-long period provides a snapshot of oral anticoagulation initiation and nonadherence among older patients with atrial fibrillation in the US.

Almost 1 in 3 High-Risk AFib Patients Not Receiving Anticoagulation

November 17, 2022

Using data from 88 medical centers across the US, new data is providing clinicians with an overview of contemporary trends in DOAC and warfarin use in adult patients with nonvalvular atrial fibrillation at high risk for stroke over the past decade.

Apixaban Trumps Other DOACs in Comparative Analysis of More than 500k AFib Patients

November 01, 2022

A comparative analysis leveraging EHR data from more than 500k new DOAC users from Europe and the US suggests apixaban use was associated with the lowest risk of gastrointestinal bleeding among agents within the class, with similar rates of thromboembolic events and mortality observed among the class.

Minority Patients with AFib Less Likely to Receive Oral Anticoagulation than White Counterparts

October 28, 2022

An analysis of the GWTG-Atrial Fibrillation Registry data suggests Black patients with AFib were 25% less likely to receive a prescription for oral anticoagulation at discharge and 27% less likely to receive a DOAC than their non-Hispanic White counterparts.

BMI in Childhood Could Signal AFib Risk Later in Life among Men

October 21, 2022

An analysis of data from linked national registries in Sweden provides clinicians with new insight into the impact of early life BMI on cardiovascular risk, particularly risk of atrial fibrillation, later in life among men.

FDA Expands WATCHMAN FLX Approval to Include DAPT Option

September 06, 2022

Announced by Boston Scientific on September 6, the label for the WATCHMAN FLX LAAC device now includes a 45-day DAPT option as an alternative to the 45-day postprocedural OAC plus aspirin regimen for patients with nonvalvular atrial fibrillation.